News & Views

U.S. Food and Drug Administration (FDA)

Latest FDA Cancer Treatment Approvals Trend Toward New Indications

What is unique about the most recent U.S. Food and Drug Administration (FDA) approvals in the oncology/hematology area is that almost all are for new indications of existing agents as opposed to new agents. This is not surprising because many of the agents target specific bioassays or tumor markers instead of a specific disease site. Oncology nurses need to be aware of the changes because treatments that they have become accustomed to giving for one indication may soon be given for others as well.

Trending Topics

View All Topics

New Gene-Based Tests Screen and Monitor for Bladder, Endometrial, and Ovarian Cancers

Genetics & genomics

New Gene-Based Tests Screen and Monitor for Bladder, Endometrial, and Ovarian Cancers

How One Institution Used Evidence-Based Practice to Reduce CAUTIs

Nursing evidence-based practice

How One Institution Used Evidence-Based Practice to Reduce CAUTIs

Writing for Wellness

Nurse self-care

Writing for Wellness

Nurse empowerment

ONS Opposes U.S. Senate’s Better Care Reconciliation Act

Nurse empowerment

ONS Issues Updated Statement on Trump Administration’s Immigration Policy

Verbal Abuse Is Still Violence, Joint Commission Says

Incivility in nursing

Verbal Abuse Is Still Violence, Joint Commission Says

Boosting T-Cell Memory Enhances Immunotherapy Effectiveness

Boosting T-Cell Memory Enhances Immunotherapy Effectiveness

CDK 4/6 Adverse Events

The Case of the CTCAE Assessment for CDK4/6 Adverse Events

How Oncology Nurses Can Support Childhood Cancer Survivors

How Oncology Nurses Can Support Childhood Cancer Survivors

fda update

U.S. Food and Drug Administration (FDA)

FDA Approves Bevacizumab in Combination With Chemotherapy for Ovarian Cancer

Which of the Following Patient Types Is Not Indicated for Lung Cancer Screening With Low-dose Helical Computed Tomography?

Which of the Following Patient Types Is Not Indicated for Lung Cancer Screening With Low-Dose Helical Computed Tomography?

APRNs Can Help Address Global Financial Toxicity

Advanced practice nursing (APN)

APRNs Can Help Address Global Financial Toxicity

fda update

U.S. Food and Drug Administration (FDA)

FDA Approves Pembrolizumab for Treatment of Relapsed or Refractory PMBCL

Skin Bacteria May Protect Against Melanoma

Skin Bacteria May Protect Against Melanoma

fda update

U.S. Food and Drug Administration (FDA)

FDA Approves Mircera for Anemia Associated With Chronic Kidney Disease in Pediatric Patients on Dialysis

Animal Therapy Has Benefits for Patients—and Healthcare Staff

Patient quality of life

Animal Therapy Has Benefits for Patients—and Healthcare Staff

fda update

U.S. Food and Drug Administration (FDA)

FDA Approves Venetoclax for CLL or SLL

cancer survivor

By 2026, How Big Is the U.S. Cancer Survivor Population Estimated To Be?

What ONS Does When the Question Can’t Be Answered Definitively

What ONS Does When the Question Can’t Be Answered Definitively

Nurse empowerment

Expert Scientists Gather to Advise ONS Research Initiatives

Immunotherapy Plus Chemo Improves Survival in Metastatic Lung Cancer

Immunotherapy Plus Chemo Improves Survival in Metastatic Lung Cancer

Biosimilar to Pegfilgrastim

U.S. Food and Drug Administration (FDA)

FDA Approves First Biosimilar to Pegfilgrastim to Decrease Cancer Treatment Infection Risk

How Do Nurse Practitioners Support Patients With Cancer During Radiation?

Radiation therapy

How Do Nurse Practitioners Support Patients With Cancer During Radiation?

The Intersection of Radiation and Medical Oncology Nursing

Radiation therapy

The Intersection of Radiation and Medical Oncology Nursing

Which Breast Cancers Benefit from Treatment With Cyclin-Dependent Kinase 4/6 Inhibitor Treatment?

Which Breast Cancers Benefit from Treatment With Cyclin-Dependent Kinase 4/6 Inhibitor Treatment?

Overcome Barriers to Applying an Evidence-Based Process for Practice Change

Putting evidence into practice (PEP)

Overcome Barriers to Applying an Evidence-Based Process for Practice Change

Here’s an Overview of the Types, Mechanisms, and Side Effects of Currently Approved Immunotherapies

Here’s an Overview of the Types, Mechanisms, and Side Effects of Currently Approved Immunotherapies

What You Need to Know About Obtaining Informed Consent

Oncology clinical trials

What You Need to Know About Obtaining Informed Consent

BRCA Mutations Point to Hereditary Breast and Ovarian Cancer Syndrome

Genetics & genomics

BRCA Mutations Point to Hereditary Breast and Ovarian Cancer Syndrome

Which Genetic Test Performed on Tumor Cells Has Prognostic and Predictive Uses?

Genetics & genomics

Which Genetic Test Performed on Tumor Cells Has Prognostic and Predictive Uses?

Financial Toxicity Discussion Needs to Include Undocumented Patients

Patient financial advocacy

Financial Toxicity Discussion Needs to Include Undocumented Patients

How to Have Ethical Discussions in Your Practice

Ethics in nursing

How to Have Ethical Discussions in Your Practice

fda

U.S. Food and Drug Administration (FDA)

FDA Reports Efficacy Issue for Patients Taking Pembrolizumab or Atezolizumab as Monotherapy to Treat Urothelial Cancer with Low Expression of PD-L1

FDA Approves Epoetin Alfa-Epbx as a Biosimilar to Epoetin Alfa

U.S. Food and Drug Administration (FDA)

FDA Approves Epoetin Alfa-Epbx as a Biosimilar to Epoetin Alfa

Huntington Disease May Hold Key to Novel Cancer Treatment

Huntington Disease May Hold Key to Novel Cancer Treatment

The Case of the Blurred Boundaries

Clinical practice

The Case of the Blurred Boundaries

How Aromatherapy With Essential Oils May Help Patients With Cancer

Complementary therapy

How Aromatherapy With Essential Oils May Help Patients With Cancer

Manage Diarrhea in Patients Receiving Nerlynx® (Neratinib) Tablets

Treatment side effects

Manage Diarrhea in Patients Receiving Nerlynx® (Neratinib) Tablets

Stay Current on Evolving Therapies in Melanoma

Advanced practice nursing (APN)

Stay Current on Evolving Therapies in Melanoma

Board Continues to Align ONS to Meet Changing Member and Healthcare Needs

ONS board of directors

Board Continues to Align ONS to Meet Changing Member and Healthcare Needs

What’s the Preferred Method for Vincristine Administration When Treating a Patient With Lymphoma or Leukemia?

What’s the Preferred Method for Vincristine Administration When Treating a Patient With Lymphoma or Leukemia?

New Eligibility Criteria for Initial Oncology Certification Begin in 2019

Nursing education

New Eligibility Criteria for Initial Oncology Certification Begin in 2019

Childhood Obesity May Be a Factor in Increasing Cancer Rates in Young Adults

Cancer risk factors

Childhood Obesity May Be a Factor in Increasing Cancer Rates in Young Adults

Find, Be, and Thank an Oncology Nursing Mentor This May

Oncology nurse pride

Find, Be, and Thank an Oncology Nursing Mentor This May

Evidence for Nephrotoxicity Prevention With Cisplatin Therapy Is Still Limited

Treatment side effects

Evidence for Nephrotoxicity Prevention With Cisplatin Therapy Is Still Limited

Nurse empowerment

Oncology Nurse Navigators Play Crucial Role in Patient Outcomes

$FDA Approves Tisagenlecleucel for Adults with Relapsed or Refractory Large B-Cell Lymphoma$

U.S. Food and Drug Administration (FDA)

FDA Approves Tisagenlecleucel for Adults with Relapsed or Refractory Large B-Cell Lymphoma

Which Is Not an ONS Recommendation When Accessing an Implanted Port?

Clinical practice guidelines

Which Is Not an ONS Recommendation When Accessing an Implanted Port?

Regular Exercise May Improve Outcomes in Patients With Lung Cancer

Regular Exercise May Improve Outcomes in Patients With Lung Cancer

Back to Top ▲